Award

Yang a 'highly accomplished crystallographer'

NIH section chief wins ASBMB's Mildred Cohn Award
Courtney Chandler
April 1, 2017

Wei Yang, an investigator and section chief of structure and mechanism at the National Institutes of Health, has won the Mildred Cohn Award in Biological Chemistry from the American Society for Biochemistry and Molecular Biology. The Cohn award honors the first president of the ASBMB and recognizes scientists who have advanced our understanding of biological chemistry through physical methodologies. Yang received the award in recognition of her work on elucidating the structure and function of proteins involved in genome maintenance.

Wei Yang
NIH

“I am thrilled and deeply humbled to receive the Mildred Cohn Award in Biological Chemistry. Dr. Cohn, an extraordinary scientist, mentor and former ASBMB president, was a pioneer and both a role model and inspiration to me and my generation of women scientists.”

— WEI YANG

Philip Hanawalt of Stanford University wrote in support of Yang’s nomination, saying he could “think of no person more deserving than Wei Yang for this recognition of a woman who has made substantial advances in understanding biological chemistry using innovative physical approaches.”

Much of Yang’s work has focused on structural characterization of proteins involved in DNA mismatch repair and translesion DNA synthesis. She has solved the crystal structures of bacterial MutL, MutS, MutH and DNA helicase II proteins in complex with their DNA substrates. This work, plus activity assays, serves as the foundation for understanding how the mismatch repair system recognizes and removes mismatched DNA to ensure high fidelity during DNA replication.

In collaboration with Roger Woodgate of the NIH, Yang’s team determined the first crystal structure of a Y-family DNA polymerase complexed with a DNA lesion and engaging in bypass synthesis. Subsequently, in collaboration with Fumio Hanaoka in Japan, who discovered human Y-family DNA polymerase eta, or Pol eta, her team elucidated the molecular mechanism Pol eta uses to bypass ultraviolet-induced DNA lesions and avoid mutations and malignancy.

“She moves smoothly from one field to another,” said Hanawalt in his letter, “always providing the insights that are derived from her understanding of fundamental crystallographic approaches.”

In more recent work, Yang and her team used time-resolved crystallographic techniques to study the mechanism of DNA synthesis. This allowed them to construct the first detailed picture of phosphodiester bond formation by a human polymerase, which included a description of the transient recruitment of a magnesium ion and interactions needed for nucleotide addition.

“Dr. Yang is both an outstanding crystallographer and an outstanding biochemist,” said Martin Gellert of the NIH in his letter of support for Yang’s nomination. “This combination of talents has enabled her to obtain deep insights into several important biological systems in the general field of DNA repair and recombination.”

Yang earned her Ph.D. from Columbia University in 1991. As a graduate student in Wayne Hendrickson’s laboratory, Yang, along with Robert Crouch of the NIH, determined the first crystal structure of RNase H bound to its RNA/DNA substrate, thereby establishing how this protein removes the RNA primers made during DNA replication. She characterized the structure and function of the UvrD helicase. This work revealed a distinct role for UvrD helicase in mismatch repair in addition to its traditional role in repairing DNA lesions produced by ultraviolet light.

Yang went on to postdoctoral fellowships at both Columbia University and Yale University. In 1995, she was recruited to the NIH as a tenure-track investigator at the National Institute of Diabetes and Digestive and Kidney Diseases.

Yang is a member of both the National Academy of Sciences and the American Academy of Arts and Sciences. She has received the Dorothy Crowfoot Hodgkin Award from the Protein Society and the Bea Singer Young Investigator Award from the Gordon Research Conference on Mutagenesis and Carcinogenesis.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a careers columnist for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.